Work

Cetuximab Plus Mfolfox-6 As First-Line Therapy for Unresectable Liver Metastasis from Colorectal Cancer: An Open, Non-Randomized, Multicenter Phase II Clinical Trial

Year: 2012

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)33115-x

Authors: S. Cai, W. Zhang, W. Li, Y. Xu, W. Gu, Z. Guan, J. Cai, C. Song, J. Xu, P. Chi

Institutions: Fudan University, Fudan University Shanghai Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Liaoning Cancer Hospital & Institute, Zhongshan Hospital, Union Hospital

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999348965

FWCI:

Cites:

Cited by:

Related to: 10